Medicine guide
LONSURF
As listed in the register: LONSURF
8.19 mg + 20 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Tipiracil (Tipiracil Hydrochloride) + Trifluridine
- Made by
- Taiho Pharma Canada, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicinesL01BC59
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Taiho Pharma Canada, Inc. |
|---|---|
| Active substance | Tipiracil (Tipiracil Hydrochloride) + Trifluridine |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 8.19 mg + 20 mg |
| Form | tablet |
| Classification | L01BC59 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02472112 |
| DPD drug code | 96139 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 8.19 mg + 20 mg
- 15 mg + 6.14 mg